What should I do if I miss taking eflornithine tablets?
When eflornithine tablets (eflornithine) are used in clinical treatment, especially when used for serious diseases such as neuroblastoma or African trypanosomiasis, it is necessary to maintain a stable blood concentration to achieve the expected effect. Once a missed dose occurs, the treatment strategy needs to be flexible according to the specific time point. If the missed dose is only for a short period of time, the dose should be taken as soon as possible; but if the next dose is approaching, the missed dose should be skipped and the medication should be continued as originally planned. Never take double doses to compensate for missed doses. This approach can easily lead to excessive blood concentration and cause toxic reactions, such as diarrhea, neutropenia, hearing impairment and other known side effects.

For patients who are receiving long-term eflornithine treatment, reminder tools should be used to help take medication on time, such as smartphone alarm clocks, pill boxes, or assistance from family members. In particular, regimens that require multiple daily medication regimens need to be strictly adhered to.
If missed doses are frequent or patients have medication compliance problems, they should proactively report to the doctor. If necessary, the medication plan can be adjusted, or even replaced with other alternative drugs that are equally effective and easier to take. In some treatment plans, eflornithine is used as maintenance therapy or adjuvant medication. Its function is to inhibit the continued activity of cancer cell proliferation signals. Therefore, treatment interruption may cause unstable efficacy and even risk of disease rebound.
In short, patients should understand the importance of taking drugs regularly, especially in the field of cancer treatment. The treatment plan itself is very strict, and any arbitrary interruption or adjustment should be avoided. Correct handling and maintaining medication regularity after missed doses are the basic guarantee for ensuring that eflornithine can exert its maximum therapeutic value.
Reference materials:https://www.drugs.com/mtm/eflornithine.html
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)